Invention Grant
- Patent Title: Peptides capable of modulating the function of TIRC7
- Patent Title (中): 能够调节TIRC7功能的肽
-
Application No.: US13338771Application Date: 2011-12-28
-
Publication No.: US09096654B2Publication Date: 2015-08-04
- Inventor: Nalân Utku
- Applicant: Nalân Utku
- Applicant Address: DE Dortmund
- Assignee: CELLACT PHARMA GMBH
- Current Assignee: CELLACT PHARMA GMBH
- Current Assignee Address: DE Dortmund
- Agency: Saliwanchik, Lloyd & Eisenschenk
- Priority: EP05010684 20050517
- Main IPC: C07K14/00
- IPC: C07K14/00 ; C07K9/00 ; C07K14/705 ; A61K38/17
Abstract:
Provided are peptides capable of inhibiting proliferation of peripheral blood mononuclear cells (PBMCs) derived from the third extracellular domain of T-cell immune response cDNA7 (TIRC7) costimulatory molecule are described. Compositions comprising such peptides and their use for the treatment of immune diseases are provided.
Public/Granted literature
- US20140154279A1 PEPTIDES CAPABLE OF MODULATING THE FUNCTION OF TIRC7 Public/Granted day:2014-06-05
Information query
